semaglutide: How do they work
How to Minimize Peptide/GLP-1 Complications Medical Monitoring Routine lab testing and physician oversight help detect problems early
The Monitoring Program includes substances which are not on the Prohibited List, but that WADA wishes to monitor in order to detect potential patterns of misuse in sport. A spokesperson for Novo Nordisk said in a statement that the pharmaceutical company, which produces and distributes GLP-1s, agreed with WADAs decision to monitor GLP-1 usage: We are supportive of the WADA recommendation, and we strongly discourage use/promotion outside the indicated population and approved label. Advertisement A spokesperson for Eli Lilly, another company that manufactures and distributes GLP-1s, said: Zepbound (tirzepatide) and Foundayo (orforglipron) are indicated for use, along with diet and exercise, for adults with obesity or overweight and a weight-related comorbidity
This is not harmful accumulation but rather the intended therapeutic level
GLP-1 medications have emerged as a valuable addition to the arsenal of treatments for type 2 diabetes, offering benefits such as improved blood sugar control, weight loss, and cardiovascular protection
None of these peptides are licensed medicines in the UK